Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Baxter
Harvard Business School
Moodys
Merck

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Chlorpropamide - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for chlorpropamide and what is the scope of freedom to operate?

Chlorpropamide is the generic ingredient in three branded drugs marketed by Ani Pharms Inc, Aurolife Pharma Llc, Dava Pharms Inc, Halsey, Mylan, Par Pharm, Sandoz, Superpharm, Usl Pharma, Watson Labs, Watson Labs Teva, and Pfizer, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for chlorpropamide.

Summary for chlorpropamide
Recent Clinical Trials for chlorpropamide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Drug Safety and Effectiveness Network, CanadaN/A
Canadian Network for Observational Drug Effect Studies, CNODESN/A
Canadian Institutes of Health Research (CIHR)N/A

See all chlorpropamide clinical trials

Medical Subject Heading (MeSH) Categories for chlorpropamide
Synonyms for chlorpropamide
1-((p-Chlorophenyl)sulfonyl)-3-propylurea
1-(4-chloro-benzenesulfonyl)-3-n-propyl-urea
1-(4-chlorobenzenesulfonyl)-3-propylurea
1-(4-chlorophenyl)sulfonyl-3-propyl-urea
1-(4-chlorophenyl)sulfonyl-3-propylurea
1-(4-Chlorophenylsulfonyl)-3-propylurea
1-(p-Chlorobenzenesulfonyl)-3-propylurea
1-(p-Chlorobenzensulfonyl)-3-propylurea
1-(p-Chlorophenylsulfonyl)-3-propylurea
1-(para-Chlorophenylsulfonyl)-3-propylurea
1-[(4-chlorobenzene)sulfonyl]-3-propylurea
1-[p-Chlorobenzenesulfonyl]-3-propylurea
1-Chloro-4-(([(propylamino)carbonyl]amino)sulfonyl)benzene #
1-p-Chlorophenyl-3-(propylsulfonyl)urea
1-Propyl-3-(p-chlorobenzenesulfonyl)urea
4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide
4-Chloro-N-((propylamino)carbonyl)benzenesulfonamide
4-chloro-N-(propylcarbamoyl)benzenesulfonamide
4-Chloro-N-[(propylamino)-carbonyl]benzenesulfonamide
4-chloro-N-[(propylamino)carbonyl]benzenesulfonamide
94-20-2
AB00051944
AB00051944_16
AB00051944_17
AC1L1EBW
AC1Q2Y2Z
ACMC-209rqj
Adiaben
AJ-26668
AK116029
AKOS001482739
AN-24283
ANW-40217
API0001972
Apo-Chlorpropamide
Asucrol
AX8120992
BCP09162
BDBM50344965
Benzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-
Benzenesulfonamide, 4-chloro-N-[(propylamino)carbonyl]-
Bioglumin
BPBio1_000359
BRD-K97746869-001-05-6
BRD-K97746869-001-15-5
BRN 2218363
BSPBio_000325
BSPBio_002013
C 1290
C1220
CAS-94-20-2
Catanil
CCG-38905
CCRIS 155
CHEBI:3650
CHEMBL498
Chlorodiabina
Chloronase
Chloropropamide
Chlorporpamide
Chlorpropamid
Chlorpropamide (JP17/USP/INN)
Chlorpropamide [INN:BAN:JAN]
Chlorpropamide [USP:INN:BAN:JAN]
Chlorpropamide B.P.
Chlorpropamide Bp/ Usp
CHLORPROPAMIDE USP
Chlorpropamide, analytical standard, >=97%
Chlorpropamide, European Pharmacopoeia (EP) Reference Standard
Chlorpropamide, Pharmaceutical Secondary Standard; Certified Reference Material
Chlorpropamide, United States Pharmacopeia (USP) Reference Standard
Chlorpropamidum
Chlorpropamidum [INN-Latin]
Clorpropamid
Clorpropamida
Clorpropamida [INN-Spanish]
Clorpropamide
Clorpropamide [DCIT]
Clorpropamide [Italian]
cMAP_000007
CPD000058364
CS-4917
CTK8B2730
D00271
DB00672
dia benese
Diabaril
Diabechlor
Diabenal
Diabenese
Diabeneza
Diabet-Pages
Diabetoral
Diabexan
Diabinese
Diabinese (TN)
Diamel Ex
DivK1c_000513
DSSTox_CID_322
DSSTox_GSID_20322
DSSTox_RID_75512
DTXSID9020322
Dynalase
EINECS 202-314-5
EU-0100229
GL6406
Glisema
Glucamide
GTPL6801
HMS1569A07
HMS1920M05
HMS2091E08
HMS2096A07
HMS2233L19
HMS3259A17
HMS3260N19
HMS3373D09
HMS3428C03
HMS3652L03
HMS3713A07
HMS501J15
HSDB 2051
HY-B1429
I14-52792
IDI1_000513
Insogen
Insulase
KB-63966
KBio1_000513
KBio2_000624
KBio2_002273
KBio2_003192
KBio2_004841
KBio2_005760
KBio2_007409
KBio3_001233
KBio3_002753
KBioGR_000808
KBioGR_002273
KBioSS_000624
KBioSS_002274
KS-00000FWW
KS-5316
Lopac-C-1290
Lopac0_000229
LP00229
LS-1959
MCULE-3261763364
Meldian
Melitase
Mellinese
MFCD00079004
MFCD00079004 (97%)
Millinese
MLS000028395
MLS001148665
MolPort-001-779-601
MRF-0000539
N-(4-Chlorophenylsulfonyl)-N'-propylurea
N-(p-Chlorobenzenesulfonyl)-N'-propylurea
N-[(4-chlorophenyl)sulfonyl](propylamino)carboxamide
N-Propyl-N'-(p-chlorobenzenesulfonyl)urea
n-propyl-N'-p-chlorophenylsu lfonylcarbamide
n-Propyl-N'-p-chlorophenylsulfonylcarbamide
N-Propyl-N'-p-chlorphenylsulfonylcarbamide
N3-Butyl-N1-p-chlorobenzenesulfonylure a
N3-Butyl-N1-p-chlorobenzenesulfonylurea
NC00503
NCGC00015216-01
NCGC00015216-02
NCGC00015216-03
NCGC00015216-04
NCGC00015216-05
NCGC00015216-06
NCGC00015216-07
NCGC00015216-08
NCGC00015216-09
NCGC00015216-10
NCGC00015216-11
NCGC00015216-12
NCGC00015216-13
NCGC00015216-14
NCGC00015216-17
NCGC00015216-18
NCGC00021451-03
NCGC00021451-04
NCGC00021451-05
NCGC00021451-06
NCGC00021451-07
NCGC00021451-08
NCGC00256414-01
NCGC00258942-01
NCGC00260914-01
NCI-C01752
NINDS_000513
Novo-Propamide
NSC 44634
NSC 626720
NSC-44634
NSC-626720
NSC-756690
NSC44634
NSC626720
NSC756690
O227
Opera_ID_359
Oradian
P 607
P-607
Pharmakon1600-01500185
Prestwick_684
Prestwick0_000323
Prestwick1_000323
Prestwick2_000323
Prestwick3_000323
Prodiaben
RKWGIWYCVPQPMF-UHFFFAOYSA-N
s4166
SAM002554890
SBB056923
SBI-0050217.P004
SC-75280
SCHEMBL23947
SMR000058364
SPBio_000018
SPBio_002246
Spectrum_000144
SPECTRUM1500185
Spectrum2_000089
Spectrum3_000347
Spectrum4_000284
Spectrum5_000719
SR-01000000060
SR-01000000060-2
SR-01000000060-4
SR-01000000060-6
ST24029048
ST50412138
Stabinol
STK857458
SW196839-3
SY052508
TC-128962
Tox21_110102
Tox21_110102_1
Tox21_201391
Tox21_302789
Tox21_500229
U-3818
U-9818
UNII-WTM2C3IL2X
Urea, 1-((p-chloropenyl)sulfonyl)-3-propyl-
Urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl-
Urea, 1-[(p-chlorophenyl)sulfonyl]-3-propyl-
Urea, 1-propyl-3-(p-chloro-benzenesulfonyl)-
W-100205
WLN: GR DSWMVM3
WTM2C3IL2X
ZINC1530599

US Patents and Regulatory Information for chlorpropamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc CHLORPROPAMIDE chlorpropamide TABLET;ORAL 089446-001 Nov 17, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz CHLORPROPAMIDE chlorpropamide TABLET;ORAL 084669-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer DIABINESE chlorpropamide TABLET;ORAL 011641-006 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
McKesson
Medtronic
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.